KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Petmed Express (PETS) Net Income towards Common Stockholders (2016 - 2025)

Petmed Express' Net Income towards Common Stockholders history spans 16 years, with the latest figure at -$10.6 million for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders fell 1322.24% year-over-year to -$10.6 million; the TTM value through Dec 2025 reached -$64.9 million, down 20059.69%, while the annual FY2025 figure was -$6.3 million, 15.98% up from the prior year.
  • Net Income towards Common Stockholders reached -$10.6 million in Q4 2025 per PETS's latest filing, down from -$8.5 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $6.5 million in Q3 2021 to a low of -$34.2 million in Q2 2025.
  • Average Net Income towards Common Stockholders over 5 years is -$2.2 million, with a median of -$42000.0 recorded in 2021.
  • Peak YoY movement for Net Income towards Common Stockholders: soared 2421.88% in 2022, then crashed 2201.39% in 2024.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at $4.4 million in 2021, then tumbled by 104.84% to -$212000.0 in 2022, then tumbled by 864.62% to -$2.0 million in 2023, then surged by 63.72% to -$742000.0 in 2024, then crashed by 1322.24% to -$10.6 million in 2025.
  • Per Business Quant, the three most recent readings for PETS's Net Income towards Common Stockholders are -$10.6 million (Q4 2025), -$8.5 million (Q3 2025), and -$34.2 million (Q2 2025).